2-benzyl-8-methoxy-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole

ID: ALA4849640

Cas Number: 69069-65-4

PubChem CID: 132599

Max Phase: Preclinical

Molecular Formula: C19H20N2O

Molecular Weight: 292.38

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2[nH]c3c(c2c1)CN(Cc1ccccc1)CC3

Standard InChI:  InChI=1S/C19H20N2O/c1-22-15-7-8-18-16(11-15)17-13-21(10-9-19(17)20-18)12-14-5-3-2-4-6-14/h2-8,11,20H,9-10,12-13H2,1H3

Standard InChI Key:  FCUJMVMWOLCXGK-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 22 25  0  0  0  0  0  0  0  0999 V2000
   23.0902  -17.7336    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4245  -17.2531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6790  -16.4769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1346  -15.8704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3355  -16.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0837  -16.8193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6299  -17.4225    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4945  -16.4764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.7442  -17.2508    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5353  -17.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0824  -16.8193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8326  -16.0449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.0359  -15.8720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3814  -15.4394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.1802  -15.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4260  -16.3895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2240  -16.5622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7736  -15.9563    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5198  -15.1751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7224  -15.0061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7885  -15.4317    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.0409  -14.6544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  9  1  0
  8  3  1  0
  2  1  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  7  2  0
  7  2  1  0
  8  9  2  0
  8 13  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 12 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  5 21  1  0
 21 22  1  0
M  END

Associated Targets(Human)

GRIN1 Tclin Glutamate NMDA receptor; GRIN1/GRIN2A (719 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Chrna3 Nicotinic acetylcholine receptor alpha6/alpha3/beta4 (315 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 292.38Molecular Weight (Monoisotopic): 292.1576AlogP: 3.73#Rotatable Bonds: 3
Polar Surface Area: 28.26Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.91CX LogP: 3.31CX LogD: 3.19
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.80Np Likeness Score: -1.00

References

1. Schwarthoff S, Tischer N, Sager H, Schätz B, Rohrbach MM, Raztsou I, Robaa D, Gaube F, Arndt HD, Winckler T..  (2021)  Evaluation of γ-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors.,  46  [PMID:34391122] [10.1016/j.bmc.2021.116355]

Source